Schonfeld Strategic Advisors LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$459,472
-50.3%
16,398
-50.2%
0.00%
-50.0%
Q3 2022$924,000
+241.0%
32,900
+321.8%
0.01%
+166.7%
Q2 2022$271,000
-66.4%
7,800
-65.3%
0.00%
-57.1%
Q1 2022$807,000
-40.4%
22,500
-67.9%
0.01%
-78.8%
Q4 2019$1,354,000
+278.2%
70,179
+312.8%
0.03%
+153.8%
Q2 2019$358,000
-59.7%
17,000
-60.9%
0.01%
-58.1%
Q1 2019$888,000
+88.9%
43,500
+70.2%
0.03%
-49.2%
Q4 2016$470,00025,5610.06%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders